CN106404683A - Stable and strong anti-interference phospholipid detection reagent and detection method thereof - Google Patents
Stable and strong anti-interference phospholipid detection reagent and detection method thereof Download PDFInfo
- Publication number
- CN106404683A CN106404683A CN201510446185.3A CN201510446185A CN106404683A CN 106404683 A CN106404683 A CN 106404683A CN 201510446185 A CN201510446185 A CN 201510446185A CN 106404683 A CN106404683 A CN 106404683A
- Authority
- CN
- China
- Prior art keywords
- reagent
- phospholipid
- detectable
- buffer
- preservative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to the technical field of phospholipid detection, particularly to a phospholipid detection reagent. According to the present invention, a sodium citrate buffer solution and a Bis-Tris Propane (1,3-bis[tris(hydroxymethyl)methylamino]propane) buffer solution are respectively used in reagents R1 and R2, wherein the Bis-Tris Propane buffer solution used in the reagent is a biological buffer solution, provides good protection effects for the peroxidase used in the reagent, and does not adversely affect the reaction system, the reagent R1 contains phospholipase D, DAOS, a Triton X-305 solution, Emulgen 707, a reducing protection agent, a chelating protection agent and a preservative, and the reagent R2 contains a buffer solution, 4-aminoantipyrine, peroxidase, choline oxidase, and a preservative; and the phospholipid detection reagent has advantages of good stability and low cost, and can be widely used in the field of phospholipid detection.
Description
Technical field
The present invention relates to phospholipid detection field is and in particular to a kind of detectable detecting phospholipid using enzymatic measurement and detection method.
Background technology
Phospholipid(Phospholipid), also referred to as phospholipid, phospholipid, refer to the lipid containing phosphoric acid, belong to complex liped.Phospholipid is to form biomembranous main component, is divided into phosphoglyceride and sphingomyelins two big class, is made up of glycerol and sphingol respectively.Phospholipid is amphiphatic molecule, and one end is the head of hydrophilic nitrogenous or phosphorus, and the other end is hydrophobic(Oleophylic)Long hydrocarbyl chain.Due to this reason, phospholipid molecule water-wet side is close to each other, and hydrophobic side is close to each other, and normal and other molecule such as protein, glycolipid, cholesterol collectively forms lipid bilayer, i.e. the structure of cell membrane.
Serum phospholipidses mainly include lecithin, LYSOLECITHIN SUNLECITHIN A, lipid sphyngomyelin and cephalin etc. four part.In clinical position, the general serum total phospholipidses that measure have chemical method and enzymatic assays two class method, such as need to check that the composition of serum phospholipidses then needs by the items technology such as thin layer chromatography, gas chromatography or high performance liquid chroma- tography further.Raise reason:Obstructive jaundice, primary biliary cirrhosiss, primary sclerosing cholangitiss, Ziere syndrome, glycogen storage disease, obesity, diabetes, acute and chronic pancreatitis, nephrotic syndrome, Hypothyroidism, fatty liver, lipodystrophy, gestation, oral contraceptive etc..Reduce reason:Hepatitis gravis, decompensated cirrhosiss, Tangier (Tangier) disease, hyperthyroidism, malabsorption syndrome, myeloproliferative diseases, multiple myeloma, Wolman disease, Leye syndrome, multiple sclerosis etc..
The method of detection phospholipid is more at present, predominantly detects the methods such as method chromatographic method, Mass Spectrometry detection method, chemical method, enzyme process.Wherein chromatograph and Mass Spectrometry detection method are the most accurate, but both approaches are higher to instrument and operator's requirement, and use cost is too expensive, is not suitable for large-area popularization.Chemical cost method is relatively low, but this method accuracy is not high, is easily interfered.Enzyme process is then relatively conventional on the market, this method is mainly carried out by means of TRINDER reaction, generate H2O2 using phospholipase and Choline dehydrogenase, carry out dye-forming reaction by chromogen, this method application is wider, low price, easy to operate, the supporting the use of suitable automatic clinical chemistry analyzer device, but this law is more because being related to enzyme, and be related to TRINDER reaction capacity of resisting disturbance inherently strong the problems such as, the problems such as existing phospholipid detectable mostly is unstable and poor anti jamming capability on the market, affects and normally use.The present invention is to solve these problems, and a kind of strong interference immunity, the enzymatic measurement phospholipid detectable of good stability and its using method have been invented in research.
Content of the invention
Problem to be solved by this invention is the detectable providing a kind of strong utilization enzymatic measurement of stability to detect serum phospholipidses.The detectable simultaneously additionally providing a kind of utilization present invention detects the detection method of serum phospholipidses.
Phospholipid hydrolyzes generation choline and phosphatidic acid in the presence of Choline phosphatase, and choline is aoxidized by Choline dehydrogenase and generates hydrogen peroxide, and hydrogen peroxide and 4-AA, DAOS react generation blue dyess.This dyestuff has maximum absorption band in 600nm, and absorption intensity is directly proportional to content of phospholipid in serum.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method, including reagent R1 and reagent R2.It is characterized in that:
Described reagent R1 comprises, and biological buffer, the wherein solute concentration in reagent R1 is 100-150mmol/L:
Choline phosphatase
0.5KU/L-2KU/L
DAOS
1.2mmol/L-3.2 mmol/L
Triton X-305
solution
1ml/L-3ml/L
Emulgen
707
0.5ml/L-2ml/L
Reduction protectants
0.5mmol/L-2mmol/L
Chelating protective agent
1mmol/L-5mmol/L
Preservative
1g/L-5g/L
Described reagent R2 comprises, and buffer, the wherein solute concentration in reagent R2 is 100-200mmol/L:
4- amino antipyrine
0.75mmol/L-1.5 mmol/L
Peroxidase
10KU/L-15 KU/L
Choline dehydrogenase
8KU/L-12KU/l
Preservative
1g/L-5g/L.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that also include in described reagent R1:Ascorbic acid oxidase 1-5KU/L.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that also include in described reagent R2:FAD2-5 mg/L and sucrose
5g/L-10g/L.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method it is characterised in that in described reagent R1 buffer be citrate buffer solution, concentration in reagent R1 for its solute is 100mmol/L, and when 25 DEG C, the pH value of buffer is 6.0.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method, it is characterized in that, in described reagent R2, buffer is Bis-Tris Propane biological buffer, and concentration in reagent R1 for its solute is 100mmol/L, when 25 DEG C, the PH of buffer is 7.1.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that described preservative is natamycin.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that chelating protective agent in described R1 reagent is HEDTA (hydroxyethylethylene diamine tri-acetic acid).
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method it is characterised in that in described R1 reagent reduction protectants be DTT (dithiothreitol, DTT).
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that the volume ratio of described reagent R1 and reagent R2 is 4:1.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that comprise the steps of:
(1)Measure reagent R1 and reagent R2;
(2)Test serum is mixed with reagent R1, records the absorbance A 1 that wavelength is during 600nm;
(3)Reagent R2 is added step(2)Mixed solution in, after 3-8min, record wavelength be 600nm when absorbance A 2.
A kind of stable, phospholipid detectable of strong interference immunity of the present invention and its detection method are it is characterised in that step(3)In response time be 5min.The preparation method of reagent R1 and reagent R2 is to measure each raw material, be added in container, mix homogeneously.
The present invention employs sodium citrate buffer solution and Bis-Tris in reagent R1 and R2 respectively
Propane(1,3- bis- [three (methylol) methylamino] propane)Buffer.Bis-Tris Propane used in reagent(1,3- bis- [three (methylol) methylamino] propane)Buffer is biological buffer, has preferable protective effect to the peroxidase used in reagent, and reaction system will not be had a negative impact.707 two kinds of surfactants of Triton X-305 solution and Emulgen are added in reagent R1; both surfactants can have the preferable emulsification improving reagent; and important toolenzyme this to Choline phosphatase has very strong protective effect, has preferable potentiation simultaneously.In order to strengthen the stability of key enzyme Choline dehydrogenase in R2 reagent, spy adds sucrose and enzymatic protective reagent FAD in R2 reagent, substantially increases the stability of enzyme.
The present invention also adds ascorbic acid oxidase and chelating agen HEDTA (hydroxyethylethylene diamine tri-acetic acid) in reagent; the interference of ascorbic acid and heavy metal ion can effectively be removed; and appropriate chelating agen HEDTA (hydroxyethylethylene diamine tri-acetic acid) protects toolenzyme Choline phosphatase, DTT with specificity(Dithiothreitol, DTT)Addition then can prevent the oxidation to enzyme for the air.
The detectable of this phospholipid has the advantages that good stability, cheap, can extensively be promoted in phospholipid detection field.
The detection method of this phospholipid, its principle is, the difference of A2 and A1, and the ratio of the difference of the numerical value being recorded using same method with titer is multiplied by the concentration of the PLIP of titer it is simply that the concentration of test serum, has the advantages that speed is fast, stability is strong.
Brief description:
Fig. 1 is the stability trendgram of formula 1, formula 2 and formula 3.
Specific embodiment:
With reference to specific embodiment, the present invention is further described.
(1)Formula 1(A kind of phospholipid detectable of existing enzymatic measurement):
The component of R1:
Citrate buffer solution(PH7.2)
100mmol/L
Choline phosphatase
0.46U/mL
DAOS
1.2mmol/L
Ascorbinase
0.6U/mL
The component of R2:
Citrate buffer solution(PH7.2)
100mmol/L
4- amino antipyrine
0.75mmol/L
Peroxidase
17U/mL
Choline dehydrogenase
7.2U/mL.
(2)Formula 2(A kind of stable enzymatic measurement phospholipid detectable of optimization):
The component of R1:
Citrate buffer solution
100mmol/L
Choline phosphatase
0.5KU/L
DAOS
1.2mmol/L
Triton X-305
solution
1ml/L
Emulgen
707
0.5ml/L
DTT(Dithiothreitol, DTT)
0.5mmol/L
HEDTA (hydroxyethylethylene diamine tri-acetic acid) 1mmol/L
Ascorbic acid oxidase
1KU/L
Preservative(Natamycin)
1g/L
The component of R2:
Bis-Tris Propane biological buffer
200mmol/L
4- amino antipyrine
0.75mmol/L
Peroxidase
10KU/L
Choline dehydrogenase
8KU/L
FAD
2mg/L
Sucrose
5g/L
Preservative(Natamycin)
1g/L.
(3)Formula 3(A kind of phospholipid detectable of the stable enzymatic measurement after key raw material increase):
The component of R1:
Citrate buffer solution
200mmol/L
Choline phosphatase
2KU/L
DAOS
3.2mmol/L
Triton X-305
solution
3ml/L
Emulgen
707
2ml/L
DTT(Dithiothreitol, DTT)
2mmol/L
HEDTA (hydroxyethylethylene diamine tri-acetic acid)
5mmol/L
Ascorbic acid oxidase
5KU/L
Preservative(Natamycin)
5g/L
The component of R2:
Bis-Tris Propane biological buffer
200mmol/L
4- amino antipyrine
1.5mmol/L
Peroxidase
15KU/L
Choline dehydrogenase
12KU/L
FAD
5mg/L
Sucrose
10g/L
Preservative(Natamycin)
5g/L.
(4)Detection method:When using using the automatic clinical chemistry analyzer with double reagent function, this detection test adopts Hitachi 7180 fully-automatic analyzer, is measured using end-point method, and detection dominant wavelength is 600nm, is measured using performance rate method.Respectively by R1 and R2 according to 4:1 ratio is placed on corresponding reagent position, places distilled water, standard substance and sample in the correspondence position of specimen disc, operating procedure such as table 1.
Table 1
Computational methods:Content of phospholipid(U/L)=(A measures ÷ A standard)× C standard.
(5)Interference is tested:Take fresh mix serum, classify in three categories part, every part is separated into 5 equal portions, add different interfering materials so as to the concentration in serum reaches the requirement of table 2, then use the reagent of formula 1, formula 2 and formula 3 respectively, measure the content of phospholipid in contrast serum simultaneously.After adding disturbance material, the measurement result of each group is shown in Table 2, mensure average × 100% of relative deviation (%)=(the mensure average of the sample of mensure average-noiseless material of interference sample)/noiseless material.
As can be seen from Table 2, ascorbic acid, bilirubin, hemoglobin and triglyceride do not substantially interfere with to the test result of formula 2 and formula 3, and the impact to formula 1 is larger, illustrates that this detectable has stronger capacity of resisting disturbance.
Table 2
.
(6)The stability test of reagent:
By the reagent in formula 1, formula 2 and formula 3,13 groups of uniform subpackage.Every group of amount of reagent:R1 is 20mL, and R2 is 5mL.It is placed in 2-8 DEG C of refrigerator, a taking-up on the same day group reagent monthly detects phospholipid quality-control product(Target value is 200mg/dL), as shown in figure 1, formula 2 and formula 3 are more or less the same, reagent is more stable than the phospholipid determination test kit in formula 1 under 2-8 DEG C of condition of storage for testing result.
Claims (10)
1. a kind of detectable of phospholipid, including reagent R1 and reagent R2, the composition of described reagent R1 and R2 is as follows:
1)The group of reagent R1 is divided into:Concentration in reagent R1 for the solute is 100-150mmol/L:
Choline phosphatase
0.5KU/L-2KU/L
DAOS
1.2mmol/L-3.2 mmol/L
Triton X-305
solution
1ml/L-3ml/L
Emulgen
707
0.5ml/L-2ml/L
Reduction protectants
0.5mmol/L-2mmol/L
Chelating protective agent
1mmol/L-5mmol/L
Preservative
1g/L-5g/L
2)The group of reagent R2 is divided into:Concentration in reagent R2 for the solute is 100-200mmol/L
4- amino antipyrine
0.75mmol/L-1.5
mmol/L
Peroxidase
10KU/L-15 KU/L
Choline dehydrogenase
8KU/L-12KU/l
Preservative
1g/L-5g/L.
2. the detectable of phospholipid according to claim 1 is it is characterised in that also include in described reagent R1:Ascorbic acid oxidase 1-5KU/L.
3. the detectable of phospholipid according to claim 1 is it is characterised in that also include in described reagent R2:FAD2-5 mg/L and sucrose 5g/L-10g/L.
4. detectable according to the arbitrary described phospholipid of claim 1-3 it is characterised in that in described reagent R1 buffer be citrate buffer solution, concentration in reagent R1 for its solute is 100mmol/L, and when 25 DEG C, the pH value of buffer is 6.0.
5. phospholipid according to claim 4 detectable it is characterised in that in described reagent R2 buffer be Bis-Tris Propane biological buffer, concentration in reagent R1 for its solute is 100mmol/L, and when 25 DEG C, the PH of buffer is 7.1.
6. the detectable of phospholipid according to claim 5 is it is characterised in that described preservative is natamycin.
7. the detectable of phospholipid according to claim 6 is it is characterised in that chelating protective agent in described R1 reagent is HEDTA (hydroxyethylethylene diamine tri-acetic acid).
8. phospholipid according to claim 7 detectable it is characterised in that in described R1 reagent reduction protectants be DTT (dithiothreitol, DTT).
9. the detectable of phospholipid according to claim 6 is it is characterised in that the volume ratio of described reagent R1 and reagent R2 is 4:1.
10. a kind of detectable of the phospholipid described in claim 7 is used for detecting the detection method of phospholipid it is characterised in that comprising the steps of:
(1)Measure reagent R1 and reagent R2;
(2)Test serum is mixed with reagent R1, records the absorbance A 1 that wavelength is during 600nm;
(3)Reagent R2 is added step(2)Mixed solution in, after 3-8min, record wavelength be 600nm when absorbance A 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510446185.3A CN106404683A (en) | 2015-07-27 | 2015-07-27 | Stable and strong anti-interference phospholipid detection reagent and detection method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510446185.3A CN106404683A (en) | 2015-07-27 | 2015-07-27 | Stable and strong anti-interference phospholipid detection reagent and detection method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106404683A true CN106404683A (en) | 2017-02-15 |
Family
ID=58009530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510446185.3A Pending CN106404683A (en) | 2015-07-27 | 2015-07-27 | Stable and strong anti-interference phospholipid detection reagent and detection method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106404683A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0488756A1 (en) * | 1990-11-30 | 1992-06-03 | Wako Pure Chemical Industries Ltd | Oxidizable color producing reagent |
CN101356283A (en) * | 2005-12-15 | 2009-01-28 | 纽约州立大学研究基金会 | Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine |
CN103717748A (en) * | 2011-07-29 | 2014-04-09 | 协和梅迪克斯株式会社 | Sphingomyelin measurement method and measurement kit |
-
2015
- 2015-07-27 CN CN201510446185.3A patent/CN106404683A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0488756A1 (en) * | 1990-11-30 | 1992-06-03 | Wako Pure Chemical Industries Ltd | Oxidizable color producing reagent |
CN101356283A (en) * | 2005-12-15 | 2009-01-28 | 纽约州立大学研究基金会 | Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine |
CN103717748A (en) * | 2011-07-29 | 2014-04-09 | 协和梅迪克斯株式会社 | Sphingomyelin measurement method and measurement kit |
Non-Patent Citations (2)
Title |
---|
浙江省食品药品监督管理局: "http://www.zj.gov.cn/art/2013/7/8/art_5525_777247.html", 《医疗器械注册审批公示(第3449号)》 * |
生物化学实验指导 等: "豆丁网文献http://www.docin.com/p-190535342.html", 《生物化学实验指导》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106383116B (en) | A kind of kit detecting high-density lipoprotein cholesterol | |
CN107449748B (en) | High-density lipoprotein cholesterol detection kit and use method thereof | |
CN101896620B (en) | Method and kit for quantification of small, dense LDL cholesterol | |
Hušková et al. | Determination of creatinine in urine by tandem mass spectrometry | |
US20020025546A1 (en) | Method of measuring substance in sample using a redox reaction | |
CN106198509A (en) | For measuring test kit and the method for creatinine | |
CN105543336B (en) | A kind of stabilization, the serum phospholipids detection reagent of strong antijamming capability and detection method | |
JP6913956B2 (en) | L-Kynurenine measurement method and measurement kit | |
KR20140096280A (en) | Blood sample assay method | |
CN106290323A (en) | A kind of stable, uric acid reagent that capacity of resisting disturbance is strong and detection method | |
EP2108961B1 (en) | Dry analytical element for measurement of high density lipoprotein cholesterol | |
CN111808921A (en) | Trinder reaction-based detection kit and application thereof | |
CN107505273A (en) | Serum tolal bile acid assay kit and its application method | |
Blackburn et al. | Active site of dopamine. beta.-hydroxylase. Comparison of enzyme derivatives containing four and eight copper atoms per tetramer using potentiometry and EPR spectroscopy | |
CN104931448B (en) | A kind of detection reagent and its detection method of lactate dehydrogenase isoenzyme 1 | |
CN111944872A (en) | Reagent combination, reagent or kit for measuring creatinine content | |
CN105385751A (en) | Total cholesterol detection reagent with high accuracy and disturbance resisting capacity | |
CN106404686A (en) | Antiheparin serum total bilirubin (vanadate oxidation method) detection kit | |
CN106367471A (en) | Kit for measuring total cholesterol and method | |
Nakashima et al. | Steady-state kinetics of NADH: coenzyme Q oxidoreductase isolated from bovine heart mitochondria | |
JP7484998B2 (en) | Biological component measurement kit and biological component measurement method with improved measurement sensitivity | |
JP2023063608A (en) | Method for suppressing decrease in sensitivity of reagent kit for measuring biological component | |
CN106885803B (en) | A kind of strong antijamming capability and the high enzyme process ethyl alcohol detection reagent of accuracy | |
CN102323225B (en) | Method and reagent kit used for detecting low-density lipoprotein cholesterin | |
CN106404683A (en) | Stable and strong anti-interference phospholipid detection reagent and detection method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |